BVF Inc’s Kindred Biosciences, Inc. KIN Stock Holding History

BVF Inc’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-51,788	Closed	-$577K	–	31
2013 Q4	$577K	Buy	+51,788	New	+$617K	0.1%	23

Other funds holding KIN

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BVF Inc's KIN Position: Q1 2014 in Review

BVF Inc sold out of Kindred Biosciences, Inc. (KIN) in Q1 2014, closing a stake of 51,788 shares — an estimated $577K sold.

BVF Inc first reported a position in KIN in Q4 2013 and held it in 1 quarter. The position peaked at $577K in Q4 2013. 39 funds tracked by Wall St. Rank hold KIN as of Q1 2014.

BVF Inc reported no remaining Kindred Biosciences, Inc. position as of Q1 2014 after selling out during the quarter.
BVF Inc sold 51,788 Kindred Biosciences, Inc. shares in Q1 2014, an estimated $577K.
BVF Inc first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 1 quarter.
BVF Inc's Kindred Biosciences, Inc. position peaked at $577K in Q4 2013.
39 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2014.

Based on BVF Inc's 13F filing for Q1 2014, filed 15 May 2014.